Abstract
Diluents, also known as fillers, are used to make up the required bulk when the drug dosage is inadequate to produce the bulk of the tablet. In the present study the effect of diluents such as Lactose, Starch and microcrystalline cellulose on the evaluation parameters of curcumin-Hydroxyl Propyl β Cyclodextrin (HPβCD) bioadhesive vaginal tablets containing Carbopol 934P, Hydroxy propyl methyl cellulose (HPMC) and Hydroxy ethyl cellulose (HEC) as bioadhesive polymers was investigated. Curcumin tablets were prepared by direct compression method and evaluated for average thickness, hardness, friability, drug content, % swelling, drug release and mucoadhesion. The FT-IR and DSC spectra revealed that there was no chemical interaction between curcumin HPβCD and diluents used. The release was observed to follow both first order kinetics and fickian diffusion. The results obtained suggest that the diluents used have significant effect on % swelling, in vitro release and mucoadhesion. From the study it was observed that using lactose or microcrystalline cellulose in the formulations resulted in faster drug release profiles when compare to starch. And lactose is the best suitable diluent for curcumin-HPβCD bioadhesive vaginal tablets.
Keywords: Curcumin, cyclodextrin, diluents, drug release, vaginal tablets.
Current Drug Therapy
Title:Influence of Diluents on Release Properties of Curcumin-Hydroxy Propyl β Cyclodextrin Bioadhesive Vaginal Tablet
Volume: 9 Issue: 2
Author(s): Umme Hani, H.G. Shivakumar, Atul Srivastava, N.G. Rashmi and Chetan G. Shinde
Affiliation:
Keywords: Curcumin, cyclodextrin, diluents, drug release, vaginal tablets.
Abstract: Diluents, also known as fillers, are used to make up the required bulk when the drug dosage is inadequate to produce the bulk of the tablet. In the present study the effect of diluents such as Lactose, Starch and microcrystalline cellulose on the evaluation parameters of curcumin-Hydroxyl Propyl β Cyclodextrin (HPβCD) bioadhesive vaginal tablets containing Carbopol 934P, Hydroxy propyl methyl cellulose (HPMC) and Hydroxy ethyl cellulose (HEC) as bioadhesive polymers was investigated. Curcumin tablets were prepared by direct compression method and evaluated for average thickness, hardness, friability, drug content, % swelling, drug release and mucoadhesion. The FT-IR and DSC spectra revealed that there was no chemical interaction between curcumin HPβCD and diluents used. The release was observed to follow both first order kinetics and fickian diffusion. The results obtained suggest that the diluents used have significant effect on % swelling, in vitro release and mucoadhesion. From the study it was observed that using lactose or microcrystalline cellulose in the formulations resulted in faster drug release profiles when compare to starch. And lactose is the best suitable diluent for curcumin-HPβCD bioadhesive vaginal tablets.
Export Options
About this article
Cite this article as:
Hani Umme, Shivakumar H.G., Srivastava Atul, Rashmi N.G. and G. Shinde Chetan, Influence of Diluents on Release Properties of Curcumin-Hydroxy Propyl β Cyclodextrin Bioadhesive Vaginal Tablet, Current Drug Therapy 2014; 9 (2) . https://dx.doi.org/10.2174/1574885509666140904000700
DOI https://dx.doi.org/10.2174/1574885509666140904000700 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ontogeny of Human Conjugating Enzymes
Drug Metabolism Letters Understanding the Concept of Chronotherapeutics in the Management of Diabetes Mellitus
Current Diabetes Reviews Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Current Protein & Peptide Science Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
Current Vascular Pharmacology The Novel Antipsychotic Drug Cariprazine and Cognition Enhancing Drugs: Indications for their Use as the Add-on Therapy in Schizophrenia
Current Pharmaceutical Design Acid Sensing Ion Channels and Acid Nociception
Current Pharmaceutical Design Advent of Proteomic Tools for Diagnostic Biomarker Analysis in Alzheimer’s Disease
Current Protein & Peptide Science Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design Brain Environment and Alzheimer’s Disease Mutations Affect the Survival, Migration and Differentiation of Neural Progenitor Cells
Current Alzheimer Research Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
Current Pharmaceutical Design Medicinal Agents and Metabolic Syndrome
Current Medicinal Chemistry Fish Oil Prevents Oxidative Stress and Exerts Sustained Antiamnesic Effect After Global Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets The Bovine Basic Pancreatic Trypsin Inhibitor (Kunitz Inhibitor): A Milestone Protein
Current Protein & Peptide Science Trans-diagnostic Validation in Neuro-psychiatry: Towards Biological Signatures of Disease
Current Topics in Medicinal Chemistry Infectious Complications with Anti-TNFα Therapy in Rheumatic Diseases: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine Recent Knowledge and New Pharmaceutical Products in Potential Alleviation of Endometriosis
Recent Patents on Inflammation & Allergy Drug Discovery (±)-3,5-Bis(substitutedmethyl)pyrrolidines: Application to the Synthesis of Analogues of glycine-L-proline-L-glutamic Acid (GPE)
Current Organic Synthesis Basic Symptoms and the Prediction of First-Episode Psychosis
Current Pharmaceutical Design Editorial [Hot Topic: Herpes Simplex Virus Type 1-Based Amplicons Vectors (Guest Editor: Alberto L. Epstein)]
Current Gene Therapy